What questions should I ask at the baseline workup stage?
The baseline workup stage is the most important stage at which to establish the diagnostic completeness of the investigation, because it is the stage at which gaps are most addressable before treatment begins. The questions that reveal gaps are rarely asked because most patients do not know what a complete workup looks like.
“What does this workup assess, and what does it not assess?” The standard fertility panel evaluates FSH, E2, AMH, LH, antral follicle count, semen analysis, and uterine anatomy. It does not assess thyroid function comprehensively (TSH only, not free T3 or T4 unless requested), subclinical insulin resistance, inflammatory markers, immune function, nutritional status, or thrombophilia in the absence of pregnancy loss. Asking explicitly what the workup does and does not assess gives the patient a map of the investigative territory and its gaps.
“Given my specific history, is there anything in the standard workup that would be particularly informative to watch?” This question invites the clinician to apply their clinical judgment to the individual rather than to the average patient. The answer reveals whether the clinician has reviewed the history specifically or is applying a default protocol.
“What would a finding of [specific marker] at the margins of normal mean for my specific situation?” Lab values at the outer edges of “normal” ranges are clinically meaningful even when they are technically within range. Asking about specific markers at borderline values produces the individualized interpretation that “your labs look fine” does not.
“What additional investigation would you consider if we do not have an explanation for the infertility after the initial workup?” This question establishes the investigative roadmap before treatment begins rather than waiting until multiple failed cycles have occurred. Research by Stacey et al. (2017) on decision aids found that patients who understood the decision criteria before an event consistently made better-informed decisions when the event occurred.
What questions should I ask after a failed cycle?
The post-cycle appointment is the highest-value clinical appointment in the treatment arc and the most frequently under-used. The questions that transform a post-cycle appointment from a next-cycle scheduling conversation into a genuine clinical review are specific and must be brought by the patient, because the appointment structure does not generate them automatically.
“Can we review the specific metrics from this cycle before discussing the next one?” This is a request, not a question, and it is the most important one to make. The post-cycle appointment defaults to next-cycle planning. Explicitly requesting the metric review before the next-cycle discussion ensures the discussion is grounded in what actually happened rather than proceeding from default protocol.
“What does our blastocyst conversion rate tell us?” The ratio of fertilized eggs that reached blastocyst stage is one of the most informative indicators of egg quality, embryo development capacity, and the efficiency of the laboratory environment. It is rarely explained without being asked. A blastocyst conversion rate below 40% from normal fertilization is clinically significant and warrants specific discussion.
“What specifically in this cycle’s data supports repeating the same protocol rather than modifying it?” This is the most important question for preventing protocol momentum. A clinician who can answer it specifically has reviewed the data. A clinician who answers generally has not, and the answer to that question is itself clinically useful information.
“What would you expect to see in the next cycle that would tell us this approach is working?” Establishing the expected markers of progress before the next cycle provides a framework for evaluating the outcome that does not depend entirely on pregnancy. A clinician who identifies specific metrics as indicators of progress is working with a testable hypothesis. A clinician who cannot identify specific expected markers may be working without one.
What questions should I ask before agreeing to the next protocol?
Protocol decisions are the most frequent significant clinical decisions in fertility treatment, and they are the decisions most frequently made without the patient understanding the clinical reasoning behind them. The questions that clarify the reasoning are specific and require preparation to ask effectively.
“What is the specific clinical rationale for this protocol for my specific presentation?” General protocols applied to individual patients are less clinically appropriate than protocols selected for individual presentations. This question asks the clinician to bridge the gap between the general protocol and the individual: what in my specific data makes this the right approach for me, rather than the default approach for most patients.
“What would change your recommendation?” This question reveals the decision criteria the clinician is using without requiring the patient to challenge the recommendation directly. A clinician who can articulate what would change the recommendation has a testable clinical model. A clinician who cannot identify any condition that would produce a different recommendation may be recommending by default rather than by reasoning.
“What are the alternatives to this protocol, and why are we choosing this one over them?” Most patients are presented with one recommendation rather than a menu of options with comparative reasoning. Asking explicitly for the alternatives and the reasoning for the selection is not a challenge to the recommendation. It is the informed consent process working as it is designed to work. Coulter and Collins’ 2011 research on shared decision-making found that patients who understood why a specific option was recommended over alternatives reported significantly higher satisfaction and lower decisional regret.
“What should I be doing in the preparation window before this cycle?” Most clinicians have specific views about what preparation matters for specific presentations. These views are rarely offered without the direct question. The answer, whether it is “nothing specific beyond the standard recommendations” or a specific nutritional, environmental, or supplementation direction, is clinically valuable and reflects the clinician’s actual assessment of what matters for this patient.
What questions should I ask when receiving a significant prognosis?
Significant prognoses, including recommendations to move to donor eggs, to discontinue treatment, or to accept a substantially reduced probability of success, are the highest-stakes clinical conversations in fertility care and the ones where the questions most rarely asked are the most important to ask.
“What specific clinical data supports this prognosis?” A prognosis should be grounded in specific clinical findings from the individual’s history, not in age-based statistics applied without individualization. A prognosis that cannot be grounded in specific clinical data from the individual is an actuarial estimate rather than a clinical assessment, and the distinction is clinically important for the decision it is intended to inform.
“What is the confidence interval around this assessment?” Most prognostic statements in fertility medicine are probabilistic rather than certain. “Your chances are very low” has a very different clinical meaning at 5% than at 25%. Asking for the specific probability range behind the assessment converts a qualitative statement into a quantitative one that the patient can evaluate against her own values about risk and continued effort.
“What would have to be different in my clinical picture for this assessment to be more optimistic?” This question identifies what the clinician sees as the primary limiting factor in the prognosis, which in turn identifies what investigation or intervention might be most relevant before accepting the assessment as final. A prognosis based on poor stimulation response is different from one based on chromosomal abnormality patterns, and the relevant next steps are different in each case.
“Is now the right moment in the diagnostic workup to accept this conclusion, or is there additional investigation that should precede it?” Significant prognoses delivered before the diagnostic workup is complete may be premature. This question is particularly important when the prognosis is delivered after fewer than three cycles, when the investigation has not included immune evaluation, thrombophilia testing, or ERA in the case of repeated implantation failure, or when a second opinion has not been sought.
What questions should I ask about what I can do between cycles?
The between-cycle preparation window is one of the most frequently under-used opportunities in fertility treatment, and the questions that activate it are almost never asked without prompting. Most patients wait for the next cycle to begin rather than using the preparation window as a clinical resource.
“Given what you know about my specific presentation, what would you prioritize in the time before the next cycle?” This is the most important between-cycle question and the one most rarely asked. Most clinicians have specific views about what is likely to matter for a specific patient. These views are not delivered as part of standard care. They are available as a response to this specific question, and the answer is individualized in a way that general fertility nutrition or supplement guidance is not.
“Are there specific markers you would want to see change before the next cycle, and if so, what do you think is most likely to influence them?” This question converts the preparation window from a general optimization effort into a targeted investigation with specific markers and specific interventions. The clinician who can name a specific marker and a specific intervention that might change it is working with a clinical hypothesis that the patient can engage with.
“Is there any specialist consultation you would recommend before the next cycle?” Reproductive immunology, functional medicine, nutritional medicine, and reproductive psychology consultations are all potentially relevant for specific presentations. Most clinicians do not refer to these specialists proactively. The direct question about whether a specialist consultation would be valuable opens a referral pathway that the default clinical interaction would not generate.
“What would you tell a close friend or family member in my situation to do in the time between cycles?” This question invites the clinician to step outside the formal clinical framework and share what they actually think matters, not just what the standard of care requires them to recommend. Many clinicians respond to this question with more specific and individualized guidance than they would offer in response to a direct clinical question, because it signals that the patient wants genuine clinical opinion rather than protocol-based advice.
The The Fertility Intelligence Hub Perspective
The appointments that changed my fertility journey were not the ones where I received the most information. They were the ones where I asked the right question. Not a list of questions, not a prepared interrogation of the clinician’s judgment. One specific question that required a specific answer and that revealed something I had not known before.
The question that changed the most for me was a version of “given what you know about my specific presentation, what would you focus on in the preparation window before the next cycle?” The answer I received, for the first time after several years of treatment, was a specific clinical observation that had been in my data all along and that had never been the subject of a direct conversation because I had never asked directly enough to produce one.
Inside The Egg Awakening, appointment preparation is treated as clinical work, not as administrative task. The From Overlooked to Empowered work includes the specific questions most worth asking at each stage of the process, because the question is what opens the clinical conversation that produces the information. The clinician has the expertise. The patient has the specific data of her own experience. The question is the bridge between them. Most patients never build the bridge because they do not know which question to ask. That is what I try to give them: not just the confidence to ask, but the specific question that is worth asking.
